AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Silent MI found in 17% of postmenopausal women: are routine ECG exams needed?(Clinical Rounds)
ORLANDO, FLA. -- More than 17% of postmenopausal women have a moderate or high likelihood of having silent myocardial infarction, based on findings from more than 60,000 women who participated in the Women's Health Initiative.
This high prevalence of silent myocardial infarction (MI) in asymptomatic women that can be detected only with an ECG suggests that it's important to get an ECG recording for all postmenopausal women, Dr. Kiran Sagar said while presenting a poster at the annual scientific sessions of the American Heart Association.
The study included 60,438 women aged 50-79 years with no symptoms of coronary disease when they entered the study. All women had a 12-lead ECG examination at baseline. The results were then categorized as low-, moderate-, or high-risk for a silent MI ...
- Health issues in postmenopausal women who drink.
- Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
- FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
- Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
- FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
- Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
- ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
- News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
- Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
- Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
- Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
- Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
- Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
- Press release article from: PR Newswire December 7, 2006 700+ words
...risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be...
- Lilly's Evista Associated with Significant Reduction of Cardiovascular Events...
- Press release article from: Business Wire February 19, 2002 700+ words
...risk of cardiovascular events in postmenopausal women participating in an osteoporosis...and treatment of osteoporosis in postmenopausal women. Evista is currently being studied...related events and breast cancer in postmenopausal women. The four-year cardiovascular...
